The Oncology Institute Announces Leadership Promotions
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) announced on Jan 9, 2026 the promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer.
Panda brings more than 25 years of IT, digital transformation, cybersecurity, and enterprise software experience, with prior leadership roles at Cisco and Infosys; he will lead TOI’s technology strategy, including AI-enablement and enterprise data privacy and security practices. Mariano, with 18 years in people operations, joined TOI in 2022 and will oversee HR Operations, Total Rewards, Learning and Development, and Talent Acquisition.
CEO Dr. Daniel Virnich said the promotions support TOI’s growth and its focus on technology-enabled, value-based community cancer care.
Positive
- None.
Negative
- None.
News Market Reaction – TOI
In the Jan 9 session, TOI declined 3.02%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 05 | Board appointment | Positive | +6.8% | New board member with capital markets and healthcare experience. |
| Dec 01 | Board resignation | Negative | -6.4% | Director resignation and start of search for new independent members. |
| Nov 13 | Earnings and guidance | Positive | -10.2% | Q3 2025 beat with raised full-year revenue and EBITDA guidance. |
| Nov 13 | AI automation deal | Positive | -10.2% | AI-enabled authorization workflow promising efficiency gains and cost savings. |
| Oct 22 | Earnings call notice | Neutral | +3.0% | Announcement of Q3 2025 results release date and conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent TOI news shows mixed alignment: governance additions and scheduling updates saw positive reactions, while strong operational and AI efficiency updates coincided with double-digit declines, suggesting the stock has at times sold off on seemingly positive fundamentals.
Over the last few months, TOI has reported several governance and operational milestones. A new board member with capital markets expertise joined effective Jan 2, 2026, which coincided with a +6.81% move. Earlier, a director resignation in Dec 2025 saw a -6.37% reaction. Q3 2025 results featured strong revenue growth and raised guidance but were followed by a -10.2% move, as was an AI automation collaboration announced the same day. Today’s leadership promotions extend this management-focused trajectory.
Key Terms
cybersecurity technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Rakesh Panda appointed Chief Information Officer
Nolan Mariano appointed Chief People Officer
CERRITOS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) announced today the promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer. These promotions reinforce TOI’s continued focus on leading the way in value-based cancer care through further development of our technology-enabled care delivery platform as well as strengthening our mission-oriented culture supported by strong leadership.
Rakesh Panda has more than 25 years of experience across IT, digital transformation, cybersecurity, and enterprise software development, including leadership roles at Cisco and Infosys. Mr. Panda will continue to guide TOI’s technology strategy, including AI-enablement efforts and enterprise-level data privacy and security practices. Nolan Mariano has 18 years of experience in People Operations and organizational leadership across several industries. Mr. Mariano joined TOI in 2022 and, as Chief People Officer, will oversee HR Operations, Total Rewards, Learning and Development, and Talent Acquisition functions.
Dr. Daniel Virnich, Chief Executive Officer at TOI, commented, “I'm extremely pleased to promote two strong internal leaders into key roles at TOI as we continue to experience rapid growth and new ways of driving world-class community-based cancer care for our patients and payor partners.”
About The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
